(Q88495344)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Maciej Niewada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Ben van Hout

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

M F Janssen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

A Simon Pickard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

8 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

Value in health regional issues

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

19-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database

25 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

The development of new research methods for the valuation of EQ-5D-5L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Lead versus lag-time trade-off variants: does it make any difference?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Dealing with the health state 'dead' when using discrete choice experiments to obtain values for EQ-5D-5L heath states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Time to tweak the TTO: results from a comparison of alternative specifications of the TTO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Valuation of EQ-5D Health States in Poland: First TTO-Based Social Value Set in Central and Eastern Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

What Influences Recommendations Issued by the Agency for Health Technology Assessment in Poland? A Glimpse Into Decision Makers' Preferences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

EuroQol: the current state of play

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Further Steps in the Development of Pharmacoeconomics, Outcomes Research, and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Lifetime costs and outcomes of repair of Tetralogy of Fallot compared to natural progression of the disease: Great Ormond Street Hospital cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

Modeling valuations for EuroQol health states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VHRI.2014.06.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VHRI.2014.06.001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29702801%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference